Exact Mass: 412.0794286
Exact Mass Matches: 412.0794286
Found 303 metabolites which its exact mass value is equals to given mass value 412.0794286,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Podophyllotoxone
Podophyllotoxone is a lactone and a lignan. Podophyllotoxone is a natural product found in Diphylleia grayi, Podophyllum peltatum, and other organisms with data available. Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1]. Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1].
Ziprasidone
C21H21ClN4OS (412.11245260000004)
Ziprasidone (marketed as Geodon, Zeldox) was the fifth atypical antipsychotic to gain FDA approval (February 2001). Ziprasidone is Food and Drug Administration (FDA) approved for the treatment of schizophrenia, and the intramuscular injection form of ziprasidone is approved for acute agitation in schizophrenic patients. Ziprasidone has also received approval for acute treatment of mania associated with bipolar disorder. [Wikipedia] D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
Cyflufenamid
C20H17F5N2O2 (412.12101219999994)
D016573 - Agrochemicals D010575 - Pesticides
Imazosulfuron
C14H13ClN6O5S (412.03566380000007)
Precursor ion, [M-H]-, is a 37Cl-isotopolog ion.; The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan. The sample was injected by direct infusion.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 19HP8024 to the Mass Spectrometry Society of Japan.
Mollicellin C
A member of the class of depsidones that is 11H-dibenzo[b,e][1,4]dioxepine substituted by hydroxy groups at positions 3 and 9, a methoxy group at position 8, methyl groups at positions 1 and 6, a 3-methylbut-2-enoyl group at position 7, an oxo group at position 11 and a formyl group at position 4. Isolated from Chaetomium brasiliense, it exhibits antimalarial and cytotoxic activities.
4-Methylamino-4-de(dimethylamino)anhydrotetracycline
Mollicellin C
Mollicellin C is produced by Chaetomium species and mutagenic mycotoxin. Production by Chaetomium subspecies and mutagenic mycotoxin.
Patientoside A
Patientoside A is found in herbs and spices. Patientoside A is a constituent of the roots of Rumex patientia (patience dock). Constituent of the roots of Rumex patientia (patience dock). Patientoside A is found in herbs and spices.
O-Deethylated candesartan
O-Deethylated candesartan is only found in individuals that have used or taken Candesartan.O-Deethylated candesartan is a metabolite of Candesartan. O-deethylated candesartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.
Zileuton O-glucuronide
Zileuton O-glucuronide is a metabolite of zileuton. Zileuton (trade name ZYFLO) is an orally active inhibitor of 5-lipoxygenase, and thus inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for the maintenance treatment of asthma. Zileuton was introduced in 1996 by Abbott Laboratories and is now marketed in two formulations by Cornerstone Therapeutics Inc. under the brand names ZYFLO and ZYFLO CR. The original immediate-release formulation of zileuton, known as ZYFLO, is taken four times per day. (Wikipedia)
(2S,3S,4S,5R)-6-(Benzo[b][1]benzazepine-11-carbonylamino)-3,4,5-trihydroxyoxane-2-carboxylic acid
Methyl (1R,2R)-2-ethyl-2,5,7,10-tetrahydroxy-6,11-dioxo-3,4-dihydro-1H-tetracene-1-carboxylate
4,7-Diphenyl-1,10-phenanthrolinesulphonic acid
C24H16N2O3S (412.08815860000004)
4-Amino-5-methylamino-2',7'-difluorescein
Glycogen Phosphorylase Inhibitor
Nitrofenac
C18H18Cl2N2O5 (412.05927180000003)
Patamostat
C20H20N4O4S (412.12052000000006)
PYRAOXYSTROBIN
C22H21ClN2O4 (412.11897760000005)
(2E)-5,7-Dihydroxy-3,6-dimethoxy-4-oxo-2-phenyl-4H-1-benzopyran-8-yl ester 2-methyl-2-butenoic acid
Bisphenol A bis(3-chloro-2-hydroxypropyl) ether
C21H26Cl2O4 (412.12080560000004)
CONFIDENCE Reference Standard (Level 1); INTERNAL_ID 5813
N-methylwelwitindolinone C isothiocyanate
C22H21ClN2O2S (412.10121960000004)
6abeta,6bbeta,12abeta,12bbeta-Tetrahydro-1,3,7,9-tetramethoxy-6H,12H-cyclobuta[1,2-c:3,4-c]bis[1]benzopyran-6,12-dione
2,3-Di-Me ether,tri-Ac-2,3,4,6,7-Pentahydroxyphenanthrene
4-(Dimethylamino)-1,4,4a,5,12,12a-hexahydro-3,10,11,12a-tetrahydroxy-1,12-dioxo-2-naphthacenecarboxamide
Dihydro-3-(.alpha.-acetoxypiperonyl)-4-piperonyl-2(3H)-furanone
3-[(1,3-Benzodioxole-5-yl)methyl]-4-[(1,3-benzodioxole-5-yl)(acetoxy)methyl]tetrahydrofuran-2-one
8-deacetylcentaurepensin-8-O-(4-hydroxy)tiglate|8-deacylcentaurepensin 8-O-(4-hydroxy)-tiglate|8-desacetylcentaurepensin-8-O-(4-hydroxytiglinate)
5,7,8-trihydroxy-3,6-dimethoxyflavone 8-O-<(E)-2-methyl-2-butenoate>
2-(3-Methoxy-4-acetoxyphenyl)-3-(acetoxymethyl)-7-methoxybenzofuran-5-carbaldehyde
3,5-Dihydroxy-7-(prenyloxy)-8-methoxy-3,4-(methylenebisoxy)flavone
(E)-2-(3-(3-bromo-4-methoxyphenyl)acrylamido)-5-guanidinopentanoic acid|subereamine A
C16H21BrN4O4 (412.07460860000003)
3-[2,2-bis(7-methoxy-1,3-benzodioxol-5-yl)ethyl]furan-2(5H)-one|peperomin G
2,3-dimethoxy-5-(2,5-dimethoxy-3,4-methylenedioxyphenyl)-7-methyl-[1,4]-naphthoquinone
1,5,8-Trihydroxy-3-methoxycarbonylmethyl-2-(3-oxopentyl)-9,10-anthraquinone
4-Hydroxy-3-methyl-6,7-(methylenedioxy)-1-(3,4,5-trimethoxyphenyl)-2-naphthoic acid|junaphtoic acid
2,3-dimethoxy-6-(2,5-dimethoxy-3,4-methylenedioxyphenyl)-7-methyl-[1,4]-naphthoquinone
15-bromo-7,16,19-trihydroxy-9(11)-pargueren-2-one
C20H29BrO4 (412.12490940000004)
(1R,3S,4S,5S,6S,7R,8S)-4beta-(chloromethyl)-3beta,4alpha-dihydroxy-8alpha-(sarracenoyloxy)-1alphaH,5alphaH,6betaH,7alphaH-guai-10(14),11(13)-dien-6,12-olide
Podophyllotoxone
d,l-Isopodophyllotoxone is a natural product found in Dysosma aurantiocaulis, Podophyllum peltatum, and other organisms with data available. Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1]. Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1].
Picropodophyllone
Picropodopyllotoxone is a natural product found in Juniperus sabina with data available. Picropodophyllone, an aryltetralin lignan, is isolated from leaves of Podophyllum hexandrum, and has antifungal activities[1][2]. Picropodophyllone, an aryltetralin lignan, is isolated from leaves of Podophyllum hexandrum, and has antifungal activities[1][2].
Ziprasidone
C21H21ClN4OS (412.11245260000004)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AE - Indole derivatives D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent CONFIDENCE standard compound; INTERNAL_ID 2747 CONFIDENCE standard compound; INTERNAL_ID 8529 Ziprasidone (CP-88059), an orally active antipsychotic agent, is a combined 5-HT and dopamine receptor antagonist[1]. Ziprasidone mesylate trihydrate has affinities for Rat D2 (Ki=4.8 nM), 5-HT2A (Ki=0.42 nM) and 5-HT1A (Ki=3.4 nM)[1].
C19H24O8S_3-[(11,13-Dihydroxy-4-methyl-2,10-dioxo-1,4,5,6,7,8,9,10-octahydro-2H-3-benzoxacyclododecin-8-yl)sulfanyl]-2-hydroxypropanoic acid
2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1(12),2,5,10,14,16,18-heptaen-20-one
2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1(12),2,5,10,14,16,18-heptaen-20-one_major
2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹?.0?,?.0¹?,¹?]icosa-1(12),2,5,10,14,16,18-heptaen-20-one
Cys Cys Gly Met
Cys Cys Met Gly
Cys Cys Ser Thr
C13H24N4O7S2 (412.10863539999997)
Cys Cys Thr Ser
C13H24N4O7S2 (412.10863539999997)
Cys Gly Cys Met
Cys Gly Met Cys
Cys Met Cys Gly
Cys Met Gly Cys
Cys Ser Cys Thr
C13H24N4O7S2 (412.10863539999997)
Cys Ser Thr Cys
C13H24N4O7S2 (412.10863539999997)
Cys Thr Cys Ser
C13H24N4O7S2 (412.10863539999997)
Cys Thr Ser Cys
C13H24N4O7S2 (412.10863539999997)
Gly Cys Cys Met
Gly Cys Met Cys
Gly Met Cys Cys
Met Cys Cys Gly
Met Cys Gly Cys
Met Gly Cys Cys
Ser Cys Cys Thr
C13H24N4O7S2 (412.10863539999997)
Ser Cys Thr Cys
C13H24N4O7S2 (412.10863539999997)
Ser Thr Cys Cys
C13H24N4O7S2 (412.10863539999997)
Thr Cys Cys Ser
C13H24N4O7S2 (412.10863539999997)
Thr Cys Ser Cys
C13H24N4O7S2 (412.10863539999997)
Thr Ser Cys Cys
C13H24N4O7S2 (412.10863539999997)
O-Deethylated candesartan
Patientoside A
(1-METHYL-1H-PYRROL-2-YL)METHYLAMINE
C23H26BrP (412.09553860000005)
Dipyrrolidino(N-succinimidyloxy)carbenium hexafluorophosphate
C13H21F6N3O3P (412.12246580000004)
9,18-DIHYDROBENZO[H]BENZO[7,8]QUINO[2,3-B]ACRIDINE-7,16-DIONE
C28H16N2O2 (412.12117159999997)
(3-amino-6-phenyl-4-thiophen-2-ylthieno[2,3-b]pyridin-2-yl)-phenylmethanone
C24H16N2OS2 (412.07040059999997)
1-(Phenylsulfonyl)indole-2-boronic acid MIDA ester,1-(Phenylsulfonyl)indole-2-boronic acid,Methyliminodiacetic acid anhydride
C19H17BN2O6S (412.09003320000005)
isoamyltriphenylphosphonium bromide
C23H26BrP (412.09553860000005)
9H-Purine,6-chloro-9-(2,3,5-tri-O-acetyl-b-D-ribofuranosyl)-
(3-Bromo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)(tert-butyl)dimethylsilane
C18H30BBrO3Si (412.12405199999995)
Pentyltriphenylphosphonium bromide
C23H26BrP (412.09553860000005)
3-nitro-4-(2-(3-phenoxybenzylidene)hydrazinyl)benzenesulfonamide
4-{3-Chloro-4-[(cyclopropylcarbamoyl)amino]phenoxy}-7-hydroxy-6-quinolinecarboxamide
Ethyl 2-[(2-hydroxy-4,5-dimethoxybenzoyl)amino]-1,3-thiazole-4-carboxylate acetate (1:1)
methyl 3-(4-methylsulfonylphenoxy)-5-phenylmethoxybenzoate
C22H20O6S (412.09805400000005)
2-[[4-[3-(4,5-dichloro-2-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulphonyl]ethanol
C18H18Cl2N2O3S (412.0415138000001)
[4,4,5,5,6,7,7,7-octafluoro-2-hydroxy-6-(trifluoromethyl)heptyl] 2-methylprop-2-enoate
Chitobiose
C12H26Cl2N2O9 (412.10152860000005)
Chitobiose is a dimer of beta-1,4-linked glucosamine units. There is ambiguity as to which structure the name refers, owing to the method by which it was first isolated. [HMDB]
Dichlorisone
C21H26Cl2O4 (412.12080560000004)
C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid
Patamostat
C20H20N4O4S (412.12052000000006)
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D015842 - Serine Proteinase Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor
O-Desethyl Candesartan
A benzimidazolecarboxylic acid that is candesartan in which the ethoxy group has been replaced by a hydroxy group. It is the inactive metabolite of the anti-hypertensive drug, candesartan.
Austocystin D
An organic heteropentacyclic compound isolated from Aspergillus and Aspergillus ustus and has been shown to exhibit cytotoxic activity. D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins D009676 - Noxae > D011042 - Poisons > D000348 - Aflatoxins
3-(2,5-dimethoxyphenyl)-6-(3,4-dimethoxyphenyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine
C20H20N4O4S (412.12052000000006)
4-(3,4-dihydro-2H-quinolin-1-ylsulfonyl)-N-(5-ethyl-1,3,4-oxadiazol-2-yl)benzamide
C20H20N4O4S (412.12052000000006)
2-Furanyl-[4-(4-phenoxyphenyl)sulfonyl-1-piperazinyl]methanone
C21H20N2O5S (412.10928700000005)
N-(5-cyclopropyl-1,3,4-oxadiazol-2-yl)-4-[methyl-(phenylmethyl)sulfamoyl]benzamide
C20H20N4O4S (412.12052000000006)
4-(dipropylsulfamoyl)-N-[5-[(methylthio)methyl]-1,3,4-oxadiazol-2-yl]benzamide
Butyl 3-(2,4-dichlorophenyl)-2-oxo-1-oxaspiro[4.5]dec-3-en-4-yl carbonate
N-(2-pyridin-3-ylpyrimidin-4-yl)-3,5-bis(trifluoromethyl)benzamide
477-49-6
Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1]. Podophyllotoxone is isolated from the roots of Dysosma versipellis and has anti-cancer activities.Podophyllotoxone is able to inhibit the tubulin polymerization[1].
Aklavinon
2,4,18-Trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.03,10.04,8.014,19]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
4-[Bis(7-methoxy-1,3-benzodioxol-5-yl)methyl]-3-methylideneoxolan-2-one
(4S,4aS,12aS)-3,10,11,12a-tetrahydroxy-6-methyl-4-(methylamino)-1,12-dioxo-4a,5-dihydro-4H-tetracene-2-carboxamide
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)
1-Phosphono-4-[4-propyl-1,1-biphenyl-4-yl]-1-butanesulfonic acid
C19H25O6PS (412.1109400000001)
methyl (Z)-2-[2-[[5-(4-chlorophenyl)-2-methylpyrazol-3-yl]oxymethyl]phenyl]-3-methoxyprop-2-enoate
C22H21ClN2O4 (412.11897760000005)
Subereamine A
C16H21BrN4O4 (412.07460860000003)
A natural product found in Suberea mollis.
(E)-N-[N-(5-Methyl-3-phenyl-isoxazole-4-carbonyl)-hydrazinocarbothioyl]-3-thiophen-2-yl-acrylamide
C19H16N4O3S2 (412.06637859999995)
3,5-dihydroxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(sulfooxymethyl)oxan-2-yl]oxybenzoic acid
2-ethoxy-N-[4-[(4-methyl-2-pyrimidinyl)sulfamoyl]phenyl]benzamide
C20H20N4O4S (412.12052000000006)
2-[3-[2-furanyl(oxo)methyl]-1-indolyl]-N-[2-(trifluoromethyl)phenyl]acetamide
C22H15F3N2O3 (412.10347160000003)
4-[[4-(Benzenesulfonyl)-1-piperazinyl]-oxomethyl]-2-methyl-1-phthalazinone
C20H20N4O4S (412.12052000000006)
methyl 8-[(2E)-2-[(6-bromo-1,3-benzodioxol-5-yl)methylidene]hydrazinyl]-8-oxooctanoate
C17H21BrN2O5 (412.06337560000003)
N-(((Cyclopropylmethoxy)imino)(2,3-difluoro-6-(trifluoromethyl)phenyl)methyl)-2-phenylacetamide
C20H17F5N2O2 (412.12101219999994)
(3S,4R,5S)-4-(tert-Butyldimethylsilyloxy)-1,1-dibromo-3,5-dimethyl-1-heptene
(7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate(2-)
Dicarboxylate anion of (7R)-7-(5-carboxy-5-oxopentanamido)cephalosporanate acid.
desmethylanhydrotetracycline zwitterion
A zwtterion obtained by transfer of a proton from the 2-hydroxy to the secondary amino group of desmethylanhydrotetracycline. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).
desmethylanhydrotetracycline
A member of the class of tetracyclines that is anhydrotetracycline in which one of the methyl groups attached to the nitrogen has been replaced by hydrogen.
15-LOX-1 inhibitor 1
C22H21ClN2O4 (412.11897760000005)
15-LOX-1 inhibitor 1 is a potent inhibitor of 15-LOX-1 (15-lipoxygenase-1) with an IC50 value of 0.19 μM. 15-LOX-1 inhibitor 1 protects macrophages from lipopolysaccharide-induced cytotoxicity. 15-LOX-1 inhibitor 1 inhibits NO formation and lipid peroxidation[1].
A 839977
A 839977 is a P2X7 selective antagonist; it blocks BzATP-evoked calcium influx at recombinant human, rat and mouse P2X7 receptors (IC50 values are 20 nM, 42 nM and 150 nM respectively) and reduces inflammatory and neuropathic pain in animal models; the antihyperalgesic effects of P2X7 receptor blockade are mediated by blocking the release of IL-1beta[1].
Chitobiose (dihydrochloride)
C12H26Cl2N2O9 (412.10152860000005)
Chitobiose dihydrochloride, a chitosan oligosaccharide, is a dimer of β-1,4-linked glucosamine units[1].
NSC45586 (sodium)
C20H17N6NaO3 (412.12597719999997)
NSC45586 sodium is an inhibitor of pleckstrin homology domain and leucine-rich repeat protein phosphatase (PHLPP). NSC45586 sodium targets the PP2C phosphatase domain in PHLPP1 and PHLPP2. NSC45586 sodium can activate AKT in neurons[1].
(1r,2r,3s)-3,5-dihydroxy-6-(7-methoxy-3-oxo-1h-2-benzofuran-1-yl)-2-methyl-4-oxo-2,3-dihydro-1h-naphthalen-1-yl acetate
5-(1-bromo-2-hydroxyethyl)-3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9ah-cyclopropa[a]phenanthren-9-one
C20H29BrO4 (412.12490940000004)
methyl (1r,2r)-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(11s,15s,16s)-16-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-triene-10,14-dione
4-(benzylsulfanyl)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C22H20O6S (412.09805400000005)
(4s)-4-[bis(7-methoxy-2h-1,3-benzodioxol-5-yl)methyl]-3-methylideneoxolan-2-one
(11s,15r)-16-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-triene-10,14-dione
1,4-dimethyl 2-(2h-1,3-benzodioxol-5-ylmethyl)-3-(2h-1,3-benzodioxol-5-ylmethylidene)butanedioate
(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl (2e)-2-(hydroxymethyl)but-2-enoate
(4s,5r,6s)-4,5-dihydroxy-6-{[3-(4-hydroxyphenyl)-4-oxochromen-7-yl]oxy}-5,6-dihydro-4h-pyran-2-carboxylic acid
(8r)-5-hydroxy-3-(4-hydroxy-2,5-dimethoxyphenyl)-8-(hydroxymethyl)-8-methylpyrano[2,3-h]chromen-4-one
2-[2-amino-1-(6-bromo-1h-indol-3-yl)ethyl]-3-(2-aminoethyl)-1h-indol-5-ol
(1s,2r,6r,7r,9r,10s,11s,12r,14s)-9-(chloromethyl)-9,11-dihydroxy-14-methyl-5-methylidene-4-oxo-3,13-dioxatetracyclo[8.4.0.0²,⁶.0¹²,¹⁴]tetradecan-7-yl (2z)-2-methylbut-2-enoate
(1r,2s,3r,4s)-2,3,4,9-tetrahydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-1-yl acetate
(5r,6s)-7-methylidene-8-oxo-5-(3,4,5-trimethoxyphenyl)-2h,5h,6h-naphtho[2,3-d][1,3]dioxole-6-carboxylic acid
7-methylidene-8-oxo-5-(3,4,5-trimethoxyphenyl)-2h,5h,6h-naphtho[2,3-d][1,3]dioxole-6-carboxylic acid
(s)-2h-1,3-benzodioxol-5-yl[(3s,4r)-4-(2h-1,3-benzodioxol-5-ylmethyl)-2-oxooxolan-3-yl]methyl acetate
3,4,5-trimethoxy-11,18,20-trioxapentacyclo[13.7.0.0²,⁷.0⁹,¹³.0¹⁷,²¹]docosa-1(22),2(7),3,5,15,17(21)-hexaene-10,14-dione
2-(2h-1,3-benzodioxol-5-yl)-3,5-dihydroxy-8-methoxy-7-[(3-methylbut-2-en-1-yl)oxy]chromen-4-one
methyl 2-{7,8-dihydroxy-1,5-dioxofuro[3,4-c]isochromen-3-ylidene}-2-(3,4-dihydroxyphenyl)acetate
3,5-dihydroxy-4-({3,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-2-yl}oxy)benzoic acid
4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione
C22H21ClN2O2S (412.10121960000004)
(1as,1bs,3r,3ar,5s,7br,9ar)-5-[(1r)-1-bromo-2-hydroxyethyl]-3-hydroxy-1a-(hydroxymethyl)-5,7b-dimethyl-1h,1bh,2h,3h,3ah,4h,6h,8h,9ah-cyclopropa[a]phenanthren-9-one
C20H29BrO4 (412.12490940000004)
(2s,3s,6r,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione
C22H21ClN2O2S (412.10121960000004)
(2r,3s,4s)-4-(benzylsulfanyl)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2h-1-benzopyran-3,5,7-triol
C22H20O6S (412.09805400000005)
(11r,15s,16r)-16-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-triene-10,14-dione
(3ar,4s,6ar,8s,9s,9as,9bs)-9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl (2e)-4-hydroxy-2-methylbut-2-enoate
[(2r,3s,4s,5r,6r)-3,4,5-trihydroxy-6-[(2-oxo-5h-furan-3-yl)methoxy]oxan-2-yl]methyl 3,4-dihydroxybenzoate
(3ar,4r,6r,6as,9s,9as,9br)-6-(chloromethyl)-6,9-dihydroxy-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,9ah,9bh-azuleno[4,5-b]furan-4-yl (2e)-4-hydroxy-2-methylbut-2-enoate
(9s,13s)-3,4,5-trimethoxy-11,18,20-trioxapentacyclo[13.7.0.0²,⁷.0⁹,¹³.0¹⁷,²¹]docosa-1(22),2(7),3,5,15,17(21)-hexaene-10,14-dione
5,7-dihydroxy-3,6-dimethoxy-4-oxo-2-phenylchromen-8-yl 2-methylbut-2-enoate
6-(chloromethyl)-6,7-dihydroxy-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl 4-hydroxy-2-methylbut-2-enoate
1-(4-chloro-1-hydroxy-3-methyl-8-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}naphthalen-2-yl)ethanone
methyl 2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
3,5-dihydroxy-6-(7-methoxy-3-oxo-1h-2-benzofuran-1-yl)-2-methyl-4-oxo-2,3-dihydro-1h-naphthalen-1-yl acetate
(2r)-2-{[3-(3-bromo-4-methoxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-carbamimidamidopentanoic acid
C16H21BrN4O4 (412.07460860000003)
7-methyl-6,8-dioxo-3-(prop-1-en-1-yl)isochromen-7-yl 3,4-dihydroxy-2-methoxy-6-methylbenzoate
16-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-triene-10,14-dione
3,17-dihydroxy-14-(hydroxymethyl)-6,6,7-trimethyl-8-oxa-15,16-dithia-12,18-diazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁵,⁹]octadeca-5(9),17-diene-4,13-dione
methyl (1s,2r)-2-ethyl-2,5,7,12-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(1r,2s,3r,4s,7s,8s,9s)-4-(furan-3-yl)-8-hydroxy-1-methyl-6,11-dioxo-5,10-dioxatricyclo[7.2.1.0²,⁷]dodecan-3-yl benzoate
(3ar,4r,6r,6as,7r,9ar,9br)-6-(chloromethyl)-6,7-dihydroxy-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2e)-4-hydroxy-2-methylbut-2-enoate
2,3,4,9-tetrahydroxy-2-methyl-5,10-dioxo-11-(λ⁵-diazynylidene)-1h,3h,4h-benzo[b]fluoren-1-yl acetate
{2-[4-(acetyloxy)-3-methoxyphenyl]-5-formyl-7-methoxy-1-benzofuran-3-yl}methyl acetate
(3ar,4r,6r,6as,7s,9ar,9bs)-6-(chloromethyl)-6,7-dihydroxy-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2z)-4-hydroxy-2-methylbut-2-enoate
methyl (1s,2r)-2-ethyl-2,5,7,9-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
1,4-dimethyl (2s,3z)-2-(2h-1,3-benzodioxol-5-ylmethyl)-3-(2h-1,3-benzodioxol-5-ylmethylidene)butanedioate
methyl 2-[(3e)-7,8-dihydroxy-1,5-dioxofuro[3,4-c]isochromen-3-ylidene]-2-(3,4-dihydroxyphenyl)acetate
14-(chloromethyl)-14-hydroxy-4,9-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradeca-7,9-dien-2-yl 2-(hydroxymethyl)but-2-enoate
(7s)-7-methyl-6,8-dioxo-3-[(1e)-prop-1-en-1-yl]isochromen-7-yl 3,4-dihydroxy-6-methoxy-2-methylbenzoate
(3s,9r)-13-chloro-14-hydroxy-9,16-dimethoxy-3-methyl-3,4,5,7,8,9,10,12-octahydro-2-benzoxacyclotetradecine-1,6,11-trione
(1s,2r,4r,6r,7z,9z,11r,14s)-14-(chloromethyl)-14-hydroxy-4,9-dimethyl-13-oxo-5,12-dioxatricyclo[9.3.0.0⁴,⁶]tetradeca-7,9-dien-2-yl (2e)-2-(hydroxymethyl)but-2-enoate
(1r,2r,3s)-3,5-dihydroxy-6-[(1s)-7-methoxy-3-oxo-1h-2-benzofuran-1-yl]-2-methyl-4-oxo-2,3-dihydro-1h-naphthalen-1-yl acetate
(2s,3s,6s,8r)-4-chloro-3-ethenyl-2-isothiocyanato-3,7,7,10-tetramethyl-10-azatetracyclo[6.6.1.1²,⁶.0¹¹,¹⁵]hexadeca-1(14),4,11(15),12-tetraene-9,16-dione
C22H21ClN2O2S (412.10121960000004)
3,5-dihydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[(sulfooxy)methyl]oxan-2-yl]oxy}benzoic acid
(2s)-3-{[(4s,8s)-11,13-dihydroxy-4-methyl-2,10-dioxo-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecin-8-yl]sulfanyl}-2-hydroxypropanoic acid
9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 4-hydroxy-2-methylbut-2-enoate
(1r,3s,7r,11r,14r)-3,17-dihydroxy-14-(hydroxymethyl)-6,6,7-trimethyl-8-oxa-15,16-dithia-12,18-diazapentacyclo[12.2.2.0¹,¹².0³,¹¹.0⁵,⁹]octadeca-5(9),17-diene-4,13-dione
2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
4-[3,7-bis(acetyloxy)-5-hydroxy-4-oxochromen-2-yl]phenyl acetate
(4s,8s)-2,4,18-trihydroxy-15-(3-hydroxy-3-methylbutyl)-7,9,13-trioxapentacyclo[10.8.0.0³,¹⁰.0⁴,⁸.0¹⁴,¹⁹]icosa-1,3(10),5,11,14,16,18-heptaen-20-one
(4s,5r,6r)-4,11-dihydroxy-13-methoxy-5-methyl-3,18-dioxo-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-2(7),8,12(17),13,15-pentaen-6-yl acetate
9-(chloromethyl)-8,9-dihydroxy-3,6-dimethylidene-2-oxo-octahydroazuleno[4,5-b]furan-4-yl 2-(hydroxymethyl)but-2-enoate
methyl (1r,2r,4r)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
3-[(7-chloro-2h-1,3-benzodioxol-5-yl)methyl]-4-isopropyl-5-[(4-methoxyphenyl)methylidene]furan-2-one
C23H21ClO5 (412.10774460000005)
7-methyl-6,8-dioxo-3-(prop-1-en-1-yl)isochromen-7-yl 3,4-dihydroxy-6-methoxy-2-methylbenzoate
3-hydroxy-6,8-dimethoxy-7-[(6-methoxy-2-oxochromen-7-yl)oxy]chromen-2-one
4-(furan-3-yl)-8-hydroxy-1-methyl-6,11-dioxo-5,10-dioxatricyclo[7.2.1.0²,⁷]dodecan-3-yl benzoate
(11s,15r,16r)-16-(3,4,5-trimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0³,⁷.0¹¹,¹⁵]hexadeca-1,3(7),8-triene-10,14-dione
3-bromo-6-[2-(carboxymethyl)-5-isopropyl-2-methylcyclopentyl]-2-hydroxy-4-methylbenzoic acid
(9r,13r)-3,4,5-trimethoxy-11,18,20-trioxapentacyclo[13.7.0.0²,⁷.0⁹,¹³.0¹⁷,²¹]docosa-1(22),2(7),3,5,15,17(21)-hexaene-10,14-dione
(7s)-7-methyl-6,8-dioxo-3-[(1e)-prop-1-en-1-yl]isochromen-7-yl 4-hydroxy-2,6-dimethoxybenzoate
2h-1,3-benzodioxol-5-yl[4-(2h-1,3-benzodioxol-5-ylmethyl)-2-oxooxolan-3-yl]methyl acetate
3-bromo-6-[(1s,2s,5r)-2-(carboxymethyl)-5-isopropyl-2-methylcyclopentyl]-2-hydroxy-4-methylbenzoic acid
4-[2-amino-1-(6-bromo-1h-indol-3-yl)ethyl]-3-(2-aminoethyl)-1h-indol-5-ol
(3s,9s)-13-chloro-14-hydroxy-9,16-dimethoxy-3-methyl-3,4,5,7,8,9,10,12-octahydro-2-benzoxacyclotetradecine-1,6,11-trione
5,7-dihydroxy-3,6-dimethoxy-4-oxo-2-phenylchromen-8-yl (2e)-2-methylbut-2-enoate
methyl 2-[4,5,8-trihydroxy-9,10-dioxo-3-(3-oxopentyl)anthracen-2-yl]acetate
(5e)-3-[(7-chloro-2h-1,3-benzodioxol-5-yl)methyl]-4-isopropyl-5-[(4-methoxyphenyl)methylidene]furan-2-one
C23H21ClO5 (412.10774460000005)
4,11-dihydroxy-13-methoxy-5-methyl-3,18-dioxo-19-oxapentacyclo[8.8.1.0¹,¹⁰.0²,⁷.0¹²,¹⁷]nonadeca-2(7),8,12(17),13,15-pentaen-6-yl acetate
(2r)-2-{[(2e)-3-(3-bromo-4-methoxyphenyl)-1-hydroxyprop-2-en-1-ylidene]amino}-5-carbamimidamidopentanoic acid
C16H21BrN4O4 (412.07460860000003)
3-[7-(2,4-dihydroxy-6-methylbenzoyloxy)-7-methyl-6,8-dioxoisochromen-3-yl]prop-2-enoic acid
(3ar,4r,6r,7r,9br)-6-(chloromethyl)-6,7-dihydroxy-9-methyl-3-methylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl (2e)-4-hydroxy-2-methylbut-2-enoate
{3,4,5-trihydroxy-6-[(2-oxo-5h-furan-3-yl)methoxy]oxan-2-yl}methyl 3,4-dihydroxybenzoate
(1s,2r,3r,4r)-5-cyano-1,2,3,7-tetrahydroxy-3-methyl-6,11-dioxo-1h,2h,4h-benzo[b]carbazol-4-yl acetate
3-[(11,13-dihydroxy-4-methyl-2,10-dioxo-4,5,6,7,8,9-hexahydro-1h-3-benzoxacyclododecin-8-yl)sulfanyl]-2-hydroxypropanoic acid
methyl (1s,2r,4r)-2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
methyl 2-ethyl-2,4,5,7-tetrahydroxy-6,11-dioxo-3,4-dihydro-1h-tetracene-1-carboxylate
(5z)-3-[(7-chloro-2h-1,3-benzodioxol-5-yl)methyl]-4-isopropyl-5-[(4-methoxyphenyl)methylidene]furan-2-one
C23H21ClO5 (412.10774460000005)